美衛生官員與Walmart會面 討論直接向患者分銷藥物
美國衛生官員本周與Walmart(WMT.US)等大型零售商會面,探討跳過製藥商、保險公司等的議價過程,直接向消費者出售藥物的計劃,令美國人可更直接向製藥商購買藥物,從而降低藥價。
據知情人士透露,會議由美國衛生與公共服務部(HHS)主持,尚未落實具體時間表及執行方案。目前美國人於Walmart等超市藥房購買藥品,牽涉製藥商、保險公司、藥房及藥品福利管理機構(PBMs)的議價過程,繁複且涉及回扣,遭批評推高藥價。
Walmart自去年10月起已提供處方藥配送服務,與亞馬遜(AMZN.US)在藥品直送市場形成競爭。是次會議反映美國政府可能進一步鼓勵零售企業直接參與藥品分銷,挑戰傳統藥品流通程序。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.